Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis.

ABSTRACT:

Objectives

To compare the outcomes of transfemoral ACURATE neo (NEO) and Sapien 3 (S3) patients in terms of device success and clinical safety outcomes using a propensity score analysis.

Background

Differences in clinical outcomes between the latest-generation balloon-expandable S3 and self-expanding NEO in a "real-world transfemoral TAVI population" are still unclear.

Methods

We compared up to 6 months clinical outcomes using a propensity score analysis (inverse probability of treatment weighting [IPTW]) to account for differences in baseline characteristics.

Results

A total of 345 patients underwent transfemoral transcatheter aortic valve implantation (TAVI) with either NEO or S3 at two centers in the Netherlands. Composite device success and early safety end

SUBMITTER: Kooistra NH 

PROVIDER: S-EPMC7984444 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature